Bloomberg Audio Studios, podcasts, radio news, The Stock Movers Report, your roundup of companies making moves in the stock market, harnessing the power of Bloomberg data. Let just take a look at some of the stocks on the move today.
We can do that with bloom Merchant, Natania, Kney, Javich, Natalia. What are you looking at today? Let's start with li Lily. The ticket is l l y. Shares are flat actually right now, but there's a big announcement. So li Lilly agreed to buy Kilonia Therapeutics for about seven billion dollars. As a result, it can get access to cutting edge treatment for blood cancer. So Kilonia's main drug aims to treat patients who have a form of blood cancer called
multiple myeloma. Now the company is enrolling patients in early stage of this trial of this of this drug. So we know that Ali Lily is mostly famous for weight loss drugs, but it is a big player in cancer space as well, after it bought a company called Loxa Oncology for about eight billion dollars in twenty nineteen. But I have to point out shares are still no Actually, it is a pretty good performance. So if you look at a twelve month basis up fourteen percent, but on
a year to date there are some losses. Yep, all right, let's stay with the pharmaceutical space. What else do you have? Yeah, so I'm watching shares of psychedelic related companies, one of them Compas Pathways. The tickers CMPs shares are done by almost futy are up excuse me, by almost forty percent. It came after President Donald Trump signed an executive order to expedite research and access to different substances used outside the US to treat post traumatic stress disorder. So this
applies to psychedelics with the so called breakthrough designation. So typically when a company does research trials, then at a lies for FDA for an approval. The typical process is about six to ten months. Now it's going to be one to two months. And analysts, of course see that as a big positive signal for those stocks. Okay, one more, what do you get? One more? Let's switch to AI space. I'm watching shares of for me. The ticker is FRMI.
Shares are down by more than twenty percent today because we got news that CEO and CFO are stepping down. So FIRMI is a developer of nuclear power for data centers. It is building a massive data center capacity in Texas. It wants to power it with nuclear capacity, but there is a problem, so the company went to public last September.
Since then, the stock dropped by more than seventy percent and the biggest concern for investors or analysts is that it still doesn't have enough tenants and as a result, it also lost one of the key anchor tenants, so lots of concerns.
The stockmover's report from Bloomberg Radio. Check back with us throughout the day for the latest roundup of companies making news on Wall Street and for the latest market moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube, Bloomberg dot com, and on Applecarplay and Android Auto with the Bloomberg Business app.